Detalhe da pesquisa
1.
Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma.
Histopathology
; 73(3): 500-509, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768723
2.
CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.
Histopathology
; 71(3): 357-365, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383817
3.
CD70 Expression and Its Correlation with Clinicopathological Variables in Squamous Cell Carcinoma of the Head and Neck.
Pathobiology
; 83(6): 327-33, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27389010
4.
First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients.
Pharmaceuticals (Basel)
; 16(3)2023 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986475
5.
Verrucous hyperplasia and verrucous carcinoma in head and neck: use and benefit of methotrexate.
Acta Clin Belg
; 76(6): 487-491, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279645
6.
Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
Pathology
; 53(7): 836-843, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217516
7.
An open-label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma.
Clin Transl Sci
; 14(6): 2300-2313, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405542
8.
Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
Pathology
; 49(4): 397-404, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28427753
9.
Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck.
Oral Oncol
; 70: 34-42, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622889
10.
TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?
Head Neck Pathol
; 11(3): 354-363, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28032290
11.
Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer.
Oncotarget
; 8(46): 80443-80452, 2017 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113315